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ABSTRACT 
 
As part of a plan launched by the Ministry of Health of Brazil to increase the availability of linear 
accelerators for radiotherapy treatment for the whole country, for which Varian Medical Systems 
company has won the bidding, a technical cooperation agreement was signed inviting Brazilian 
Scientific and Technological Institutions to participate in a technology transfer program. As a 
result, jointly, the Eldorado Research Institute and the Center for Biomedical Engineering of the 
University of Campinas presents in this work, the concepts behind of a proposed rule engine to aid 
in the evaluation and decision-making in radiotherapy treatment planning. Normally, the 
determination of the radiation dose for a given patient is a complex and intensive procedure, which 
requires a lot of domain knowledge and subjective experience from the oncologists’ team. In order 
to help them in this complex task, and additionally, provide an auxiliary tool for less experienced 
oncologists, it is presented a project conception of a software system that will make use of a hybrid 
data-oriented approach. The proposed rule engine will apply both inference mechanism and 
expression evaluation to verify and accredit the quality of an external beam radiation treatment 
plan by considering, at first, the 3D-conformal radiotherapy (3DCRT) technique. 
 
Keywords: Rule engine, External beam radiation therapy, 3D-confomal radiotherapy, Planning 
evaluation, Arden syntax 
A. INTRODUCTION 
Cancer, considered one of the most worldwide problem in oncology healthcare system, is a 
coined term used to refer to a large set of diseases that share as a main characteristic the disordered 
growth of cells, that usually invades tissues and organs, and which may eventually can spread out to other 
regions of the body. The source of its cause is diverse, and as such, may be related to habits and lifestyle, 
infectious agents, sociocultural and geographical environment, genetic predisposition, among others [1, 2, 
3]. 
Within the Brazilian reality, according to the National Institute of Cancer of Brazil [In 
Portuguese: Instituto Nacional de Câncer José Alencar Gomes da Silva – INCA] the estimate for 
2012/2013 was around 518 thousands new cases of cancer. Of which, near 258 thousand were men whilst 
260 thousand were women, being their predominant occurrence in age groups over 50 years. The data 
also indicates that cancer represents the second cause of death in the Brazilian population. 
Notwithstanding, in another study, a projection by the International Agency for Research Cancer (IARC) 
indicates that, in Brazil, in 2030, there will be more than 733 thousands new cases of cancer, excepting 
those of non-melanoma skin. As a result, it represents an increase of approximately 54% compared to the 
same data from 2015 [4]. 
Radiation treatment planning is a very intensive interactive process composed of several activities 
in an image-guided scheme (e.g. CT, PET and/or MRI image slices) for devising an appropriate external 
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beam radiotherapy or internal brachytherapy treatment for a patient with cancer. The objective is to 
provide a safe, accurate, easy-to-use tool for the clinical planning in order to maximize the radiation dose 
to the tumour (target volume) and minimize it to the surrounding healthy tissues [5]. 
Commonly, a team consisting of physician oncologists, medical physicists and dosimetrists carry 
out this process with the aid of software specifically tailored to serve as a clinical decision-support system 
for radiotherapy treatment. Those software makes possible for the oncologist team to executes sequences 
of target contours in the tissue region of interest, determine the beam field and calculates the radiation 
dose to be delivered to the patient, just to mention a few, for a chosen clinical modality (e.g. 3D-
conformal radiotherapy – 3DCRT, Intensity-modulated radiation therapy – IMRT or Volumetric 
modulated arc radiotherapy – VMAT). 
B. THE TECHNOLOGY TRANSFER PROGRAM CONTEXT 
In order to expand the offer of radiotherapy treatment within the public healthcare system of 
Brazil (In Portuguese: Sistema Único de Saúde – SUS), the Brazilian Ministry of Health has launched a 
plan in 2012 that included the installation of up to 80 linear accelerators equipment throughout the 
country. Additionally, as part of the agreement between the Brazilian Ministry of Health and Varian 
Medical System, the Radiotherapy Public Call Notice nº 001/2016 invited the Brazilian Scientific and 
Technological Institutions [In Portuguese: Instituições Científicas e Tecnológicas – ICTs] interested to 
participate in a technical cooperation with Varian Medical Systems for a technology transfer program. 
Stemming from this events, jointly, the Eldorado Research Institute [In Portuguese: Instituto de 
Pesquisas Eldorado (ELDORADO)] and the University of Campinas, through its Center for Biomedical 
Engineering [In Portuguese: Universidade Estadual de Campinas, através do Centro de Engenharia 
Biomédica – CEB-UNICAMP] formed an ICT, and as such, were selected to participate in two programs. 
The first, named, Training in Embedded Software Engineering for Linear Accelerators, held in Palo Alto, 
California, in the USA, and the second, called, 3D Treatment Planning, in Helsinki – Finland. Therefore, 
the present article is the result of the challenge launched in the aforementioned Radiotherapy Public Call 
for the second project to conceive ways to simplify/improve the 3D conformal radiotherapy treatment 
planning in the context of Brazil and, more specifically, for the SUS. 
C. THE PROPOSED PROJECT AND ITS GOALS 
In oncology, the radiotherapy treatment planning is a very complex task due to the difficulties 
imposed for planning the radiation dose to delivery, or even to defining the contouring area and volume of 
an organ to receive the radiation without harming the surround ones for a given patient. As a result, the 
decision-making becomes a complex task because it requires a lot of domain knowledge and subjective 
experience of the oncologists and medical physicists in the front of clinical practice [6]. 
Although there are a plenty of clinical practice guidelines that are disease-specific 
recommendations to support clinical decision-making in accordance with the best evidence, usually, they 
are not often integrated into the front lines of care [7]. Additionally, with the amount of healthcare 
information available around of the world, produced by clinical trials (either recent papers discussing 
results, or ongoing clinical trials), and case series, beside of academy, industry and regulatory institutions, 
make the task of being up-to-date practically impossible for the professionals working on the front of 
clinical practice. 
To deal with those challenges, looking at the Brazilian oncology ecosystem, the ELDORADO 
and CEB-UNICAMP proposes the project of developing a rule-based system concerned to the 
radiotherapy treatment planning. This project takes a hybrid data-oriented approach that will apply 
inference mechanism and expression evaluation engine to verify and accredit the External Beam 
Radiotherapy Treatment (EBRT) plan quality, considering the 3DCRT technique. 
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The aim of this project if to create a decision support system that incorporates the wealth of 
experience possessed by experts, policies, standards and guidelines, by applying inverse planning strategy 
in a hybrid data-oriented rule engine to evaluate a treatment plan (in any stage). 
The main objectives sought are: 
 To improve intra- and inter-planner consistency; 
 To insert both the context and particular culture of each radiotherapy/oncology center in the 
definition of the treatment plan; 
 To identify plan quality prognostic features that can be used to improve the treatment plan 
quality; 
 To enable the development of both qualitative and quantitative metrics for plan quality 
evaluation and assessment 
Figure 1 depicts the roles and responsibilities of ELDORADO, CEB-UNICAMP and the Clinics 
Hospital of UNICAMP, where the latter represents the Oncology Healthcare System for this technology 
transfer program. As one can observe, the ELDORADO got in charge of the project design, value 
proposition and software development. In turn, the CEB-UNICAMP received the task of providing both 
the clinical purpose and the scientific evaluation. Finally, the Clinics Hospital of UNICAMP contributed 
by offering the physician’s intention and use case as well as the clinical evaluation. 
 
 
Figure 1 - The roles and responsibilities of the Eldorado Research Institute, CEB-UNICAMP and the Clinics 
Hospital of UNICAMP for the project development of the proposed rule-based system during the Technology 
Transfer Program. 
D. THE VERY BASICS OF RADIOTHERAPY TREATMENT 
Radiation therapy relies on the concept that fast proliferating cells (i.e. cancer cells) are more 
sensitive to ionizing radiation than healthy cells. Long story short, ionizing radiation is a form of energy 
derived from electromagnetic waves that carry enough energy to knock electrons from atoms or 
molecules. Usually, high energy x-rays, or sometimes, electrons, and more rarely protons, are used as 
sources for oncology treatment [8]. 
However, excessive radiation adversely affects all cells, including healthy tissue and critical 
organs. The aim of radiation therapy is to deliver a tumouricidal dose over the tumour region while 
minimizing the radiation received by healthy tissue and critical organs in the vicinity of a tumour or in the 
radiation beam path. Its application can cure many cancers by destroying the tumour or stopping it from 
growing any further. However, the determination of a suitable radiotherapy dose to be delivered during 
the treatment is a very important and complex process, since it concerns a trade-off between the expected 
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benefit, in terms of the cancer control, and the harmful side effects, in terms of the patient survival and 
quality of life [8, 9]. 
The process from diagnosis to treatment contains many steps as one can see in Figure 2, which 
presents a basic radiotherapy treatment workflow. In a few words, depending on the outcomes of a 
medical appointment, the physician oncologist can indicates a radiotherapy treatment to the patient, and 
as such, the next step will be make the patient go through for an imaging scan. The most common medical 
imaging techniques used to the end of localizing tumours are computed tomography (CT), magnetic 
resonance imaging (MRI) and positron emission tomography (PET) [10]. Nonetheless, these imaging 
systems allow 3D reconstruction of tumours and other organs for treatment planning. In turn, a process 
known as image registration is needed to match the spatial information obtained by different imaging 
techniques. 
 
 
Figure 2 - Basic diagram of a radiotherapy treatment workflow. 
  
In treatment planning, tumours and organs at risk are determined, and treatment parameters, such 
as the number and angles of beams, the modality and energy of radiation, and the intensity for each beam 
are chosen. Dose calculation involves models of the physical behaviour of radiation as it interacts with 
matter to determine dose distribution to the patient. Finally, the patient is treated, with the planned 
treatment delivered in fractions over a period of time, followed by clinical evaluation and treatment 
follow-up stages (Figure 2). 
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APPROACHES AND CHALLENGES 
Advances and improvements in medical technologies and computer hard- and software made 
possible the radiotherapy treatment to progress for 3D planning and, more than that allowed a computer-
controlled delivery mechanism. Forward and inverse planning are two ways of approaching radiotherapy 
planning. The former treatment plan determines the dose distribution through interactive adjustments of 
the planning parameters to achieve an acceptable value, whilst the latter requires the prior specification of 
the dose distribution to create the treatment plan that fits the prescribed dose distribution [11]. 
Figure 3 shows a 3DCRT forward planning where one can see the all the common steps involved 
from 3D planning to its conclusion. Moreover, it makes clear how demanded is the efforts needed by the 
oncologist team to meet a feasible and safe radiation therapy for a given patient.  
 
 
Figure 3 – A conventional 3DCRT forward planning [Modified from the Radiotherapy Public Call Notice nº 
001/2016 issued by the Ministry of Health of Brazil]. 
 
 The general process sketched by a 3DCRT forward planning follows as: 
1. The oncologist views the patient’s CT images and outlines the GTV (gross tumour volume), 
CTV (clinical target volume), PTV (Planning target volume) and OAR (organ at risk) on the 
images. 
2. Then, the beams are placed so that they intersect at the isocenter (usually, the center of the 
tumour). The other parameters, such as beam weights, wedges and multi-leaf settings, are 
determined. 
3. The dose distribution is calculated by the treatment planning system and evaluated with 
respect to the planning goals. 
4. The beam configuration and the other parameters are modified. 
5. Steps 2 to 4 are repeated until the dose distribution is satisfactory. 
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Normally, medical physicist shares three or four treatment plans with physician oncologists 
containing advantages and disadvantages of each plan. Those plans comes with the dose distribution 
objectives, based on the available patient information as well as their collection of image files. As a 
response, from the physician’s feedback, the physicists may modify the treatment plan. Consequently, the 
outlined procedure are both time consuming and inefficient processes [12]. 
Depending on the cancer types, many institutions prefer to fix the dose limits to a tumour and 
OARs. Then, the treatment planning parameters has the goal of determining the delivered dose 
distribution as close as possible to the prescribed dose objectives. As a result, the inverse planning can 
produce radiation treatment plans that are superior to the forward planning. Notwithstanding, the 
generation of a good treatment plan can varies from a few hours to a few days, in complicated cases, and 
as such, it requires the expertise of experienced medical staff. Further, ideal dose distribution, in which no 
OAR and healthy tissue overdosed, and the tumour tissue is not underdosed, is impractical [13]. 
Additionally, as both the tumour and healthy cells interleaves themselves in the tissue, the dose allowed 
to be applied is limited, such that, the radiation should be appropriate to destroy the tumour cells without 
killing the healthy ones [14]. Besides that, the treatment plan has to (must) take into account standards, 
procedures, hospital policies, capabilities, recommendations and guidelines. Treatment goals also depend 
on other factors: 
Age of patient/Stage of cancer: Younger patients often receives a more aggressive treatment, 
whereas in older or terminally ill patients, more importance to the quality of the remaining life rather than 
completely removing the tumour is given. 
Organs-at-risk (OAR): Different OARs respond differently to radiation [14]. Some organs like 
kidney, liver, lung, among others, are known as rope organs due to their somehow sensitiveness of losing 
some part of itself, and as such, in a radiotherapy treatment plan, such rope organs as a whole have to be 
protected from uniform dosage delivered. Other organs, like spinal cord, bowel, for instance, called chain 
organs are also very sensitive of losing some parts of themselves, whereas they are somehow resistant to 
relatively high levels of radiation applied to the whole organ. As a result, during a treatment planning 
procedure, one needs to watch out for unusually high dosages delivered even to the small parts of such, 
category of organs. 
Apart from that, the decision variables or the treatment plan parameters primarily concern the 
dose and the beam configuration and includes [12]: 
 Total radiation dose: The radiation dose depends on the type and location of the tumour, 
and the total radiation is fractioned on the course over a specific time duration. This 
procedure is applied because healthy cells recover faster than the tumour ones, while still 
keeping tumour control. 
 Beam configuration: The beam configuration is determined by the specific patient anatomy, 
which includes both the location and the shape of the tumour as well as the OARs in the 
vicinity of the target volume for treatment. 
 Number of beams: In 3DCRT, the radiation is applied using a certain number of beams, in 
different directions, with the aim of reducing the total radiation dose applied to the healthy 
tissue in the beam's path. Usually, the number of beams can vary from 2 to 9, and its 
determination depends on the hospital policy for the sake of ease and effectiveness of 
implementation. 
 Beam weights: The beam weights denote the intensity of each beam. Given a total prescribed 
radiation dose that the tumour has to receive, the individual beams can be weighted 
differently to make up the total dose. 
 Angle of beams: The beams are applied at an angle to ensure that they conform to the tumour 
volume while avoiding as much as possible the OARs. The can be applied coplanar (all lying 
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in one plane) or non-coplanar. There are also physical constraints about beam placement, for 
instance, the radiation beams should not be directed at the patient from directly underneath 
the treatment bed (couch). 
 Wedges: Wedges are metallic wedge-shaped blocks, which are placed in the path of the beam 
to attenuate the radiation. 
 Multi-leaf collimator settings: the leaves of the collimator shape the radiation beam. 
Protocols to specify relationships between both conformal dose distributions and results of 
imaging studies can be derived from computable clinical guidelines and rules languages. Rules can 
perform the specification for radiation dose in known tumour volumes, in areas of suspected microscopic 
spread, while it can also determines the needed tolerances for patient motion. 
Further, rules can also specify to non-target structures the maximum radiation dose is allowed to 
be delivered. Even more, rules can be formulated to criticizing and reviewing the conformal dose 
distributions generated by the medical physicists (e.g. the radiation treatment planners), in addition to 
potentially serves as a way of assisting in the generation of new radiation treatment plans. Lastly, rules 
tha would recommends conformal dose distributions during the course of a treatment could also 
incorporate changes in both GTV and CTV over time, along with observed radiation toxicity effects [12]. 
E. A RULE-BASED SYSTEM OVERVIEW 
Rule-based systems, also known as knowledge-based systems or expert systems, are an 
application of artificial intelligence (AI) to systems in involving human-crafted rule sets. It were 
conceived as a simplified way of creating some description of how to solve a problem that otherwise 
would be extremely complicated if were applied just a conventional algorithm development for 
knowledge representation of a person or group with expertise in a given field. For that reason, rules are a 
feasible way of encoding a human expert’s knowledge in a narrow area (or niche) into automated system. 
Additionally, as a sub-class of AI, knowledge representation is concerned with how knowledge is 
represented and manipulated, being very useful systems for reasoning, with the end of process data, to 
infer conclusions [15]. 
From that perspective, rule-based systems are software systems based on rule engine components. 
The term “rule engine” might be quite vague because it can be any system that uses rules, in any form, 
that can be applied to data to produce outcomes. Put differently, a rule engine works by evaluating 
collections of facts and using the results to determine new facts [16]. 
Essentially, rule engines are used to make inferences. Based on a validation-expression 
evaluation, a rule engine can generates (infer) an answer to a user’s question in accordance with its both 
possessed rules definitions and data that it can have access. Alternatively, a rule engine can be oriented to 
infer some information from a given set of data in the absence of receiving a specific question, just based 
on the rules contained in the engine [17]. 
Further, rule-based expert systems evolved from a more general class of computational models 
knows as production systems [18]. A production system is Turing complete, and is conceived to express 
propositional and first order logic in a concise, non-ambiguous and declarative manner [19]. Instead of 
viewing computation as a pre-specified sequence of operations, production systems view computation as 
the process of applying transformation rules in a sequence determined by the data. A classical production 
system has three major components: (1) a global database (working memory) that contains facts or 
assertions about the particular problem being solved, (2) a rule base (production memory) that contains 
the general and specific knowledge about the problem domain, and (3) a rule interpreter (inference 
engine) that carries out the problem-solving process. 
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The facts in the global database can be represented in any convenient formalism, such as arrays, 
strings of symbol, list structures, etc. The rule is a two-part structure using first-order logic for reasoning 
over knowledge representation, and preferably, the given statement is advantageous: 
WHEN <condition> THEN <action> 
Thus, consider for instance the following set of prescription facts (or findings) related to the risk 
of prostate cancer: 
Prescription Facts (Findings) 
 Tumour Location: C61.9, the code that refers to a Prostate Cancer 
 Tumour Stage: T2aN0M0, the code sequence that give details of the lesion extension as 
follows: 
o T2a: The tumour involves one-half or one side of the prostate 
o N0: No regional lymph nodes 
o M0: No metastasis 
 PSA (Prostate-Specific Antigen): 8ng/ml 
 Gleason Score: 6, which is the grading system used to determine the aggressiveness of 
prostate cancer – typical range between 6-10) 
Based on the gathered set of facts above, one can establish a rule with a [WHEN] and [THEN] 
structure as follows: 
 Rule 1: [When] the Tomour Location is C61.9 (Prostate), and the Primary Tomour Stage T is 
T1a, T1b, T1c or T2a, and the Lymph Node Stage is N0, and the Metastasis Stage is M0, and 
PSA < 10ng/ml, and Gleason Score ≤ 6, [Then] Classify the Tumour as a Low Recurrence 
Risk Prostate Cancer. 
 Rule 2: [When] Low Recurrence Risk Prostate Cancer, [Then] apply 3D-CRT or IMRT with 
dose of 75 to 79.2Gy up to 44 fractions with maximum dose per fraction of 1.8Gy. 
Hence, Figure 4 depicts a basic diagram example that illustrates parts of a rule-based system 
using a set of data under certain conditions to obey some rules. 
 
Figure 4 – Diagram showing the basics of a rule-based system. 
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In general, the condition part or sensory precondition [WHEN], the left-hand-side (LHS) of a rule 
can be any pattern that can be matched against the database. Once a match is achieved, the action part 
[THEN], the right-hand-side (RHS) of the rule can be executed. Such action can be also any arbitrary 
procedure employing the bound variables. 
In turn, the rule interpreter, or inference engine, has the task of deciding which rules to apply. The 
rule interpreter for a classical production system executes in a “recognize-act” cycle. It turns out that the 
rule interpreter cycles through the condition parts of the rules, looking for one that matches the current 
database, and executes the associated actions for (some or all) rules that satisfy that condition. 
Typically, the inference engine, as shown in Figure 5, has three components: Pattern Matcher, 
Agenda and Execution Engine. The Pattern Matcher compares the data of rules and facts and adds the 
rules that satisfy the facts into Agenda. In turn, Agenda manages the execution sequence of the rules 
which Pattern Matcher chooses, and Execution Engine executes these rules. A system with a large 
number of rules and facts may result in many rules being true for the same fact assertion; these rules are 
said to be in conflict. The Agenda manages the execution order of these conflicting rules using a Conflict 
Resolution strategy. 
Forward chaining and backward chaining are primarily the two modes of operation of inference 
engines. The former starts with the available data and uses inference rules to extract more data until 
reaching a goal. Thus, an inference engine that uses a forward chaining, search the inference rules until it 
finds one where the antecedent (LHS) is known to be true. When such rules are found, the engine can 
make a conclusion or infer the consequent (RHS), which results in the addition of new information to its 
data. This iterative process will happen until to reach an established goal [19]. 
On its part, backward chaining starts with a list of goals (or hypothesis) and works, as its name 
indicates, backwards from the consequent to the antecedent to verify whether any data supports any of 
these consequents or not. An inference engine that uses a backward chaining would search the inference 
rules until it finds one with a consequent (RHS) that matches an established goal. If the antecedent (LHS) 
of that rule is unknown to be true, then it is added to the objective list (i.e. for one’s goals to be confirmed 
one must also provide data that confirms this new rule) [20]. Table 1 summarizes the pros and cons 
between forward and backward chaining [21]. 
 
 
Figure 5 - The components of an inference engine (rule interpreter) [Modified from [34]]. 
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Table 1 - Comparison between forward and backward chaining [21] 
Forward chaining Backward chaining 
Starts with the initial facts Starts with some hypothesis or goal 
Asks many questions Asks few questions 
Tests all the rules Tests some rules 
Slow Fast 
Provides a huge amount of information from just 
a small amount of data 
Provides a small amount of information from just 
a small amount of data 
Attempts to infer everything possible from the 
available information 
Searches only that part of the knowledge base that 
is relevant to the current problem 
Primarily data-driven Goal-driven 
Uses inputs; searches rules for answer 
Begins with a hypothesis; seeks information until 
the hypothesis is accepted or rejected 
Top-down reasoning Bottom-up reasoning 
Works forward to find conclusions from facts 
Works backward to find facts that support the 
hypothesis 
Tends to be breadth-first Tends to be depth-first 
Suitable for problems that start from data 
collections 
Suitable for problems that starts from a hypothesis 
Non-focused; it infers all conclusions from data, 
may answer unrelated questions 
Focused; questions all focused to prove the goal 
and search as only the part of knowledge-base that 
is related to the problem 
Explanation not facilitated Explanation facilitated 
All data is available 
Data must be acquired interactively, i.e., on 
demand 
A small number of initial states but a high number 
of conclusions 
A small number of initial goals and a large 
number of rules match the facts 
Forming a goal is difficult Easy to form a goal 
All the same, while both forward and backward chaining rules engines can, in some cases, 
provide powerful reasoning capabilities for arriving at solutions, the time taken to get such answers is 
difficult to predict. These rules engines belong to the category of non-deterministic ones. Differently, the 
third class of rule engine known as deterministic utilize domain-specific language (DSL) approaches for 
better describing policies. Thus, deterministic rules engines have more predictable and consistent 
behavior, and as such, are suited for applications that intend to implement a stated set of policy rules [20]. 
F. KNOWLEDGE REPRESENTATION MODEL 
Rule-based systems, an applied AI in a knowledge specific domain, makes the knowledge 
representation model the most important ingredient for developing an AI system. Hence, knowledge 
representation and reasoning concerns to representing information about a specific domain such that a 
computer system can utilize to solve complex tasks, such as diagnosing a medical condition or the 
planning of a 3D radiotherapy treatment for targeting a tumour. 
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It turns out that the inference engine needs a computationally compliant format to represent the 
incoming data per a set of rules [22, 23, 24]. The format of such rules as used by a specific rule engine 
can be set out as the knowledge representation model. Examples of knowledge representation models 
commonly employed in the biomedical and computer science domains, just to mention a few, includes: 
context-specific Boolean rules, suchlike those set in the Mycin clinical decision-support system [25, 26], 
complex axiomatic statements like those employed by the Arden syntax for medical logic modules [27, 
28, 29], and frames such as those used in numerous biomedical ontologies and intelligent agents [23, 24, 
30, 31]. 
In defiance of many advances in both knowledge representation and inference technologies 
approaches, the production rules remain the most prevailing because it allows express first-order logic 
declaratively in an unambiguous human readable form, whilst keeping machine interpretability. Table 2 
depicts an overview of the advantages and disadvantages of applying production rules mechanisms. 
Consequently, despite its procedural role in systems, essentially, rules are declarative representations [32]. 
Table 2 - Advantages and disadvantages of declarative representation [32] 
Advantages of production rules Disadvantages of production rules 
Compact representation of general knowledge: 
Rules can easily represent general knowledge 
about a problem domain in autonomous, relatively 
small chunks. 
Naturalness of representation: Rules are a very 
natural knowledge representation method, with a 
high level of comprehensibility. 
Modularity: Each rule is a discrete knowledge 
unit that can be inserted into or removed from the 
knowledge base, without taking care of any other 
technical detail (as long as other rules are not 
affected). 
Provision of explanations: The ability to provide 
explanations for the derived conclusions in a 
straightforward manner. 
 
Knowledge acquisition bottleneck: The standard 
way of acquiring rules through interviews with 
experts is cumbersome and time-consuming. 
Brittleness of rules: It is not possible to draw 
conclusions from rules when there are missing 
values in the input data. 
Inference efficiency problems: In certain cases, 
the performance of the inference engine is not the 
desired one, especially in very large rule bases. 
Difficulty in maintenance of large rule bases: 
The maintenance of rule bases is getting a 
difficult process as the size of the rule base 
increases. The rule base may have problems such 
as, redundant rules, conflicting rules, rules with 
redundant or missing conditions, missing rules, 
etc. 
Problem solving experience is not exploited: A 
rule-based system is not self-updatable, in the 
sense that there is no inherent mechanism to 
incorporate experience acquired from dealing with 
past problems. 
Interpretation problems: The general nature of 
rules may create problems in the interpretation of 
their scope during reasoning. 
With this in mind, one of the most comprehensive knowledge representations in clinical 
terminology in use around the world is the one called SNOMED CT, which stands for Systematized 
Nomenclature of Medicine -- Clinical Terms, and was the chosen one adopted in our project. Among its 
benefits, one can noticed the following, extracted from their own website [33]: 
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a. Electronic health records that allows the access to relevant and critical clinical information, in 
addition to, the increasing opportunities for real time decision support to more accurate 
retrospective reporting for research, data analytics, precision medicine and management; 
b. Benefits for individuals, as it removes language barriers offering multi-language support, it 
also allows accurate and comprehensive analysis that identify patients who require follow-up 
or changes of treatment improve communication, among others; 
c. Benefits for population, by allowing early identification of emerging health issues, 
monitoring of population health and agile response to changing clinical practices. 
Additionally, it enables accurate access to relevant information, reducing costly duplications 
and errors, just to mention a few; 
d. Evidence-based healthcare, because it enables links between clinical records and clinical 
guidelines, can enhances the quality of care, raising its cost-effectiveness. Further, it can limit 
the frequency and impact of adverse healthcare, just to citing some of the benefits. 
As an illustration of the power of SNOMED CT system for knowledge representation in cancer 
data, Figure 6 depicts the net of terminologies associated with carcinoma of breast (based on the 
International Classification of Diseases number 10, ICD-10). As one can observe, the presented ontology 
net connects the disorders with the associated findings, allowing the establishment of a huge and complex 
interconnection of knowledge for that specific type of cancer. 
KNOWLEDGE REPRESENTATION ISSUES 
For specific problems, regardless of the knowledge representation language chosen, may be 
essential to represent it and reason on it with spatial models, temporal relations, compound objects, 
possible worlds, beliefs and expectations. Hence, issues suchlike consistency, completeness, robustness 
and transparency are equally important in the construction of a knowledge base for expert systems, and as 
such, plays the major design considerations functions [18]. Therewithal, still according to the authors of 
[18]: 
Much of the knowledge flowing out of an expert is uncodified and comes with uncertainty. Then, 
it is unrealistic to assume that the knowledge base can be sufficiently cleansed to withstand a logician’s 
scrutiny. As a result, consistency in the knowledge base is obviously desirable. 
On its part, syntactic and semantic completeness are both important issues that must be taken 
account of in knowledge representation. The former refers to a logical requirement that many rule-based 
languages fail to satisfy (e. g. assertions as quantified statements that are difficult or impossible to 
express), whereas, the latter, refers to the meaning of symbols, and as such, it will almost certainly fail to 
cover some interesting (sometimes important) possibilities because the cost of checking all combinations 
for completeness is prohibitive. Thus, the best way of checking the completeness of rules coverage made 
by an inference system is by choosing carefully the test cases. 
In turn, capability of representing properly the degrees of imprecision is an important part of 
every representation methodology, especially because there would be a temptation of making overly 
precise assertions for the knowledge base, even when there is no justification for fine precision. 
Consequently, precision in specialized domains is feasible for many of the facts and rules, but certainly it 
will not achieve for all. At the same time, default knowledge is an important protection against 
incompleteness, but generally, it requires stating the default for each class of actions explicitly.  
Typically, causal models provide a detailed specification of how complex devices works, whether 
it be biological or mechanical. For its part, temporal relations, as causal ones, are still generally difficult 
to represent and use in satisfactory ways. Lastly, although strategies for problem-solving are a very 
important part of expertise, they are also difficult to represent and to use it efficiently. 
13 
 
 
Figure 6 - Example of a knowledge representation model of a breast carcinoma based on the SNOMED CT system 
[Modified from the “NCI Workshop: The Role of Ontology in Big Cancer Data Session 3: Cancer big data and the 
Ontology of Disease Bethesda, Maryland May 13, 2015” – PDF document]. 
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DECISION TABLE 
Decision tables are a way of structuring conditional logic into a tabular form. In this context, 
conditional logic relates to a set of tests that will give rise of a set of actions. Four quadrants are one of 
the most common shapes of a decision table used to organize conditional logic as one can see in Figure 7. 
The upper two quadrants named the condition stub and condition entry, describe conditions for which 
logic must be tested. Thus, condition stub represents the list of conditions or tests, whilst condition entry 
indicates for each column what results from each condition is necessary for this column to execute. 
Conversely, the lower two quadrants describe the actions to be taken depending on the outcome 
of the condition tests together with the associated actions. The action stub label represents the list of 
actions to be performed and the action entry field provides, for each column, an “X” mark for each action 
that should be executed. 
  
 
Figure 7 - Structure of a decision table. 
 
In the end, a decision table is considered balanced or complete if it includes every possible 
combination of input variables (i.e. balanced decision tables prescribe an action in every situation where 
the input variables are provided. With balanced decision tables, the user defines “every” path through the 
logic, while with unbalanced ones, the user defines only a subset of paths through the logic. Thence, 
unbalanced decision tables reduce the clutter and complexity even further, and as such, enhance the table 
ability to represent the logic behind the table. Additionally, unbalanced tables, in favor of documenting 
the policy more clearly, sacrifice, in response, the goal of documenting every path through the logic [34]. 
G. THE PROPOSED RULE-BASED SYSTEM ARCHITECTURE 
The proposed rule-based architecture comprises two layers, named as rule engineering layer and a 
fact extraction layer. Figure 8 depicts the diagram block and the components of the system. The rule 
engineering layer has five main features: Rule editor, Ontology manipulator, MLM validator, 
MLM2Code translator, MLM repository, inference mechanism. 
 The rule editor provides an user interface for physicians to creating and editing sharable rules 
and treatment planning evaluation criteria in a Ripple-Down Rules (RDR) fashion, using 
Arden Syntax MLM constructor and decision tables, based on concepts and terminology from 
a Domain Specific Ontology – including/acquired from NCCN Guidelines, RTOG, 
QUANTEC, ICD-O and TNM standards, among others – and from SNOMED CT. 
 The ontology manipulator extracts the domain concepts and maps it to an instruction set. 
 MLM validator verifies the syntax of rules according to the Arden Syntax, and both rule 
consistency and compatibility (e.g. duplication, conflict). 
 MLM2Code translator transform the standard MLM into executable classes. 
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 The MLM repository stores valid MLMs and classes (mapping). 
 Differently from [35], the proposed inference mechanism has four components: pattern 
matcher, agenda, execution engine, and an evaluation criteria invoker. The pattern 
matcher compares the patient facts and prescription rule data and adds the rules which satisfy 
the facts into agenda. Agenda manages the execution sequence of the rules which pattern 
matcher chooses, and execution engine execute these rules. The execution engine loads 
guidelines, similar cases, and the decision tables/associated rules into the user interface. The 
user interacts with the evaluation criteria invoker, using the decision tables/associated rules 
loaded (questions) that requests evidence to the data extraction layer and returns an answer 
(fail/pass). 
In turn, the fact extraction layer is responsible for acquiring facts, data and attributes from a 
database. This layer has two components, namely fact provider and data manipulator. 
 Fact provider is a middleware that queries and manages data acquisition, processing and 
transformation services based on the fact requested by the evaluation criteria invoker 
component. 
 The data manipulator processes and manipulates data from database using specialized 
application and tools, when requested by the fact provider. 
Hence, the key architectural features of the proposed system can be summarized as follows: 
 Passive: The engine only executes decisions when explicitly invoked by the user. 
 Stateless: The engine does not store state or data between activations. 
 Executable: All decisions are compiled into an executable code. 
 Deterministic: For a given input and rule set, the path to derive the output is defined. 
 Standardize Knowledge Base: Knowledge base realized by using standard knowledge 
representation units of Medical Logic Modules (MLM), using HL7 Arden Syntax, and 
SNOMED CT and ICD-O standard terminology. 
EVALUATION CRITERIA CLASSIFICATION 
To allow partial verification of a treatment plan, under a specific aspect, the rules for evaluation 
and accreditation should be segmented into classes, as follows: 
 Preconditions: Check the adherence of the preconditions to the specific ontology and the 
completeness of the set of preconditions and data associated with the definition of the 
applicable set of rules. 
 Conventions and nomenclatures: Include rules associated with the specific domain 
dictionary and the conventions for readability and uniformity of the plan. 
 Regions, structures and organs at risks: Rules and recommendations (guides) on the 
regions and structures that should be outlined in the particular treatment. Among the rules are 
the obligation to delineate a particular organ or the existence of a region; the limits of a 
structure date, for example the applicable minimum volume, or its relationship with other 
structures, etc. For the recommendations (which cover the rules that require active 
intelligence for its verification), are the anatomical location of a region date, or its extension. 
 Constraints and dosage: Rules associated with the adherence of the plan to the prescription 
and distribution of radiation by body, structures and regions. QUANTEC recommendations, 
T5/5 and T50/5 are examples of this class of rules. 
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 Quality criteria: The rules in this class verify a finalized plan regarding pre-established 
criteria for its quality. Number and extent of hot spots and cold spots, homogeneity and 
compliance index, dose obtained from monitor units from machine calibration data, etc. 
 
 
Figure 8 - The proposed architecture for the rule-based system to be used in radiotherapy treatment planning. 
17 
 
PATIENT DATA 
The data from the patient becomes eligible to be stored in the system only when a primary tumour 
diagnosis has been confirmed, which means that the database should only reflect the completed medical 
diagnosis. The patient data is described by specific characteristics of a tumour, associated radiation 
therapy treatments and examinations, which can include temporal and factual data. 
In turn, tumour-specific characteristics lie in either primary tumour diagnosis, local and opposite 
mammary recurrences (as the ICD-0 and TNM codes) or metastatic recurrence (as location). Treatments 
includes a prescribed dosage of radiation, its fractions, radiation beam path, and so on. In addition, 
examinations are represented by a collection of medical images, Gleason scores, blood and urine tests, 
just to mention a few [12]. 
Ultimately, it is expected that the patient data should be stored in structured fields, using the 
domain-specific ontology, in order to speed up the patch matcher process.  
WORKFLOW 
The workflow represents how the proposed architecture should behave. Thus, it is provided an 
overview of how the data ought to be treated by this system.  
First, the system determines the applicable rules for a particular prescription. Thus taking up the 
example of prostate cancer prescription as shown in Figure 4, rewritten here for convenience, we have: 
Prescription Facts (Findings) 
 Tumour Location: C61.9, the code that refers to a Prostate Cancer 
 Tumour Stage: T2aN0M0, the code sequence that give details of the lesion extension as 
follows: 
o T2a: The tumour involves one-half or one side of the prostate 
o N0: No regional lymph nodes 
o M0: No metastasis 
 PSA (Prostate-Specific Antigen): 8ng/ml 
 Gleason Score: 6, which is the grading system used to determine the aggressiveness of 
prostate cancer – typical range between 6-10) 
In this step, the system acts as an expert system and tries to find the set of rules applicable to the 
facts. In that case: 
 Rule: [When] the Tomour Location is C61.9 (Prostate), and the Primary Tomour Stage T is 
T1a, T1b, T1c or T2a, and the Lymph Node Stage is N0, and the Metastasis Stage is M0, and 
PSA < 10ng/ml, and Gleason Score ≤ 6, [Then] CLASSIFY the Tumour as a Low 
Recurrence Risk Prostate Cancer and LOAD Low Recurrence Risk Prostate Cancer 
EVALUATION CRITERIA, GUIDELINES, CASES, etc. 
The system then operates as a validation/expression evaluation engine. In other words, in a 
pass/fail fashion) A user interacting with the Evaluation Criteria Invoker can ask specific questions stated 
by the set of evaluation criteria organized into classes (Preconditions; Conventions and nomenclatures; 
Regions, structures and OARs; Constraints and dosage; Quality criteria). Some examples are: 
 Precondition rule (Low Recurrence Risk Prostate Cancer): 
o The treatment technique should be 3DCRT or IMRT 
o The total dose should be ≥ 75 and ≤ 79.2 Gy 
o The number of fractions should be ≥ 44 
o The maximum dose per fractions should be ≤ 1.8Gy 
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 Conventions and nomenclatures: 
o The contour of the CTV (Clinical Target Volume) should be dark blue 
o The contour of the GTV (Gross Target Volume)  should be red 
o The structure name should obey the domain ontology 
 Regions, structures and OARs rule (Low Recurrence Risk Prostate Cancer): 
o The rectum should be delineated 
o The bladder should be delineated 
o 45% of the small bowel volume should be < 195cc (entire potential space within 
peritoneal cavity) 
 Constraints and dose rule (Low Recurrence Risk Prostate Cancer): 
o 80% of the bladder volume should be irradiate with less than 15% of the prescription 
dose (V80 < 15%) OR 65% of its volume should be irradiate with less than 17% of 
the prescription dose (V65 < 17%) 
o 100% of the PTV should be irradiate with more than 98% of the prescription dose 
(V100 > 98%) 
o The maximum point dose in the PTV (Planning Target Volume) should be less than 
107% of the prescription dose 
o The mean dose to the penile bulb should be < 52.5Gy. 
 Quality criteria rule (Low Recurrence Risk Prostate Cancer): 
o The conformity index should be < 1.4 
o The number of cold spots (regions within PTV with dose ≤ 95% of the prescription 
dose) should be zero 
o The homogeneity index should be > 0.98 
 
In some cases, the question cannot be answered directly by the data in the treatment plan, as for 
instance in the determination of the conformity index and the homogeneity index. In that case, the rule 
engine request specialized/advanced data processing to fulfill the facts needed.  
In other cases, active intelligence is required to answer the question. As an illustration, the 
anatomical determination of the nodal CTV boundaries (prostate cancer), which should have superior 
margin greater than the junction of outer and inner iliac vessels, but not superior to the junction of 
common iliac vessels. In this case, it cannot be verified without the use of an active intelligence (natural 
or artificial) to distinguish and determine the compliance with this particular rule. For rules that require 
active intelligence, the system provides the rule and guideline, and in response, requests the user to 
confirm the plan's compliance. 
CONCLUSION AND FUTURE WORK 
It was presented the concepts of a proposed rule-based system aimed to be designed and 
implemented as a software system solution to aid Oncology Healthcare Institutions in Brazil suchlike the 
Clinics Hospital of UNICAMP. The main conception behind of its proposal is to offer somehow a way of 
simplify the user workflow of 3D radiotherapy treatment planning, and additionally, provide a way of 
improve the quality assessment of the plans for the oncologists team, helping them in evaluating and 
decision-making process, reducing in a certain sense, the planning mistakes possibly made in clinical 
practice. 
Notwithstanding, the proposed solution is applicable in Big Data applications, and therefore, 
expansible to the Brazilian Public Health System as a whole, as it is possible to combine the rule engine 
with the machine learning field. The conceived architecture can be used within the specific context and 
reality of each existent Oncology Treatment Center in Brazil as a whole. More than that, the desired and 
intended application of this software system are to fill, in the future, the gap between the renowned 
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Brazilian centers of reference for cancer treatment and those smaller and more distant centers located in 
the countryside of Brazil, where it is known that there is a shortage of more qualified professionals. 
As a result, the idea will be to provide to those limited centers access to clinical practices 
practiced by those reference centers in order to create a national standard radiotherapy treatment planning 
for entire Brazil. 
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